Remove tag health-economics
article thumbnail

STAT+: Pharmalittle: Some employers cut insurance coverage for weight loss drugs; U.S. urges ADHD pill makers to boost production

STAT

health care system billions annually even as it remains out of reach for many lower-income seniors most likely to suffer from dementia , KFF Health News explains. Besides the $26,500 annual price tag, treatment could cost U.S. Besides the $26,500 annual price tag, treatment could cost U.S. could qualify to use the drug.

article thumbnail

Cost of disease-modifying therapies for multiple sclerosis continues to rise in US

Pharmaceutical Technology

DMTs for MS have a high price tag, particularly in the US. This economic burden may deter some patients from seeking treatment, while others might decide to stop taking their treatment altogether. However, they cannot provide a cure and have a very limited impact on halting disease progression.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

On November 2, the Institute for Clinical and Economic Review (ICER) released its updated evidence aimed at measuring the clinical effectiveness and cost of the two haemophilia gene therapies. A previous October 2020 report concluded that longer-term safety and efficacy were needed to update health-benefit price benchmarks.

FDA 111
article thumbnail

FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag

pharmaphorum

That was the damning conclusion of the influential Institute for Clinical and Economic Review (ICER) in the US to yesterday’s approval of Aduhelm (aducanumab), the first new treatment for Alzheimer’s since 2003, which it says has “no evidentiary basis.” billion in 2027. .

FDA 98
article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Two gene therapies up for approval this year for sickle cell disease could be cost effective in some cases at a $2 million price point, based on a draft evidence report published by the Institute for Clinical and Economic Review (ICER).

FDA 59
article thumbnail

Addressing Cultural Competency: Healthcare for Refugees & Minority Populations

Colors Make me Happy

Years of economic sanctions and multiple home displacements had already made life difficult. For Fatima, family stability was the ultimate goal — to travel across the ocean to America was the only possibility of providing it, along with good health. Unless a health issue requires immediate, prompt care, trips to the doctor are avoided.

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

Other Affiliations: Angela is an active Board of Director member of the Pfizer Foundation (a charitable organization addressing global health challenges), European Federation of Pharmaceutical Industries and Associations (EFPIA), and UPS (the global leader in package delivery and supply chain logistics). LinkedIn Total experience: 35 yrs.

FDA 40